Tomio Furuta Selected Research

YHO-13351

7/2011

Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomio Furuta Research Topics

Disease

3	Neoplasms (Cancer) 01/2012 - 01/2010
2	Lung Neoplasms (Lung Cancer) 07/2011 - 01/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Colonic Neoplasms (Colon Cancer) 07/2011
1	Leukemia 07/2011
1	Leukemia P388 07/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2011
1	Breast Neoplasms (Breast Cancer) 07/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2010
1	Carcinoma (Carcinomatosis) 01/2010

Drug/Important Bio-Agent (IBA)

3	Irinotecan (Camptosar)FDA LinkGeneric 01/2012 - 01/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2011
1	ProdrugsIBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	YHO-13177IBA 07/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2011
1	YHO-13351IBA 07/2011
1	amrubicinolIBA 01/2010
1	amrubicinIBA 01/2010

Therapy/Procedure

1	Transplantation 01/2012
1	Drug Therapy (Chemotherapy) 07/2011
1	Therapeutics 01/2010